The effects and safety of CBD
CBD is considered safe to use though there are many ongoing clinical trials investigating its effects.
This research is vital prior to any legalisation for medicinal use or recreational use. Several pharmaceutical companies continue to investigate, and recently GW Pharmaceutical released interim results of its clinical trials which stated:
“The safety profile of CBD was particularly reassuring, with no serious adverse events and an overall frequency of adverse events very similar to a placebo.
The most common adverse events (occurring in 5% or more patients resulting from all causes) were Diarrhoea, Nausea and Headaches."
Other pharmaceutical companies are beginning to add CBD to their product range.
Furthermore, the ‘Current Drug Safety’ (US publication) cited Bergamaschi (2011) to confirm that:
“CBD is non-toxic, does not affect physiological parameters (heart rate, blood pressure and body temperature), does not affect gastrointestinal transit and does not alter psychomotor or psychological functions. High doses up to 1,500 mg/day of CBD are reportedly well tolerated in humans.